LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-10-14
Case ID: NM_000314.8_c.-491_-486dup_20261014_133106
Framework: ACMG/AMP 2015
Variant classification summary

NM_000314.8:c.-491_-486dup

PTEN  · NP_000305.3:p.?  · NM_000314.8
GRCh37: chr10:89623724 A>AGCGGCG  ·  GRCh38: chr10:87863967 A>AGCGGCG
Gene: PTEN Transcript: NM_000314.8
Final call
Benign
BA1 stand-alone benign BS2 supporting
All criteria require review: For research and educational purposes only.
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.?
gnomAD AF
0.001393968304446918 (v4.1)
ClinVar
Likely benign
OncoKB
Interpretation summary
Generated evidence synthesis
1
Benign: gnomAD v4.1 allele frequency 0.001394 exceeds the PTEN BA1 threshold of >0.00056.
2
Benign evidence: gnomAD v4.1 reports three homozygous observations, meeting PTEN BS2 supporting criteria.
Final determination: Under Rule17 of the ClinGen PTEN Expert Panel Version 3.2 framework, one met BA1 stand-alone benign criterion is sufficient for a Benign classification.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: the six-base 5' UTR GGC-repeat duplication has predicted protein consequence NP_000305.3:p.(=), not a coding loss-of-function change.
cspec vcep_pvs1_decisiontree_pten
PS1 N/A Not applicable: the 5' UTR insertion has protein consequence p.? and therefore no amino-acid change for PS1 comparison.
cspec
PS2 Not assessed Not assessed: no documented de novo proband or parental testing was available to satisfy the PTEN PS2 requirement for confirmed maternity and paternity.
cspec
PS3 Not assessed Not assessed: mmc2.xlsx has no entry for c.-491_-486dup, p.?, or p.(=), and no qualifying variant-specific functional assay result is available.
cspec vcep_mmc2
PS4 Not assessed Not assessed: no exact-variant case-control odds ratio, p value, confidence interval, or PTEN phenotype-specific proband score is available for comparison with the PS4 thresholds.
cspec gnomad_v4
PM1 N/A Not applicable: the 5' UTR insertion has no protein residue, whereas PTEN PM1 requires residues 90-94, 123-130, or 166-168.
cspec
PM2 Not met Not met: gnomAD v4.1 AF 0.001394 is far above the PTEN PM2 threshold of <0.00001.
cspec gnomad_v4 gnomad_v2
PM3 N/A Not applicable: the PTEN VCEP version 3.2 explicitly designates PM3 as not applicable.
cspec
PM4 Not met Not met: predicted protein consequence NP_000305.3:p.(=) shows no protein-length change, and the variant is upstream of all PTEN catalytic motifs.
cspec
PM5 N/A Not applicable: the 5' UTR insertion is not missense and has protein consequence p.?, so no same-residue PM5 comparison is possible.
cspec pm5_candidates
PM6 Not assessed Not assessed: zero documented assumed de novo observations were available against the PTEN PM6 minimum of one disease proband without confirmed maternity and paternity.
cspec
PP1 Not assessed Not assessed: zero informative meioses or affected relatives were documented, below the PTEN PP1 Supporting threshold of 3 or 4 meioses.
cspec
PP2 N/A Not applicable: PP2 requires a missense variant, but this 5' UTR insertion has protein consequence p.?.
cspec
PP3 N/A Not applicable: the upstream c.-491_-486 duplication has protein consequence p.? and is outside PP3's missense or intronic/splice-region scope.
cspec
PP4 N/A Not applicable: the PTEN Expert Panel specification incorporates phenotype specificity into PS4 and explicitly excludes independent PP4 use.
cspec
PP5 N/A Not applicable: no exact-variant ClinVar expert-panel Pathogenic or Likely pathogenic classification exists, and PTEN VCEP marks PP5 unavailable.
cspec clinvar
BA1 Met Met: gnomAD v4.1 all-comers AF 0.001394 exceeds the PTEN BA1 threshold of >0.00056.
cspec gnomad_v4 gnomad_v2
BS1 Not met Not met: gnomAD v4.1 AF 0.001394 is above the PTEN BS1 upper limit of 0.00056 and meets BA1 instead.
cspec gnomad_v4 gnomad_v2
BS2 Met Met at supporting strength: gnomAD v4.1 reports three homozygotes, exceeding the PTEN rule requiring two observations without clinical data.
cspec gnomad_v4 gnomad_v2
BS3 Not assessed Not assessed: mmc2.xlsx has no entry for c.-491_-486dup, p.?, or p.(=), and no qualifying benign functional or splicing assay result is available.
cspec vcep_mmc2
BS4 Not assessed Not assessed: no affected-family segregation comparison was documented, while the PTEN BS4 Supporting threshold requires lack of segregation in one family.
cspec
BP1 N/A Not applicable: the PTEN VCEP marks BP1 not applicable, and this 5' UTR insertion is not a missense variant.
cspec
BP2 Not met Not met: no documented trans observation or at least three cis/unknown-phase observations with pathogenic or likely pathogenic PTEN variants.
cspec clinvar
BP3 N/A Not applicable: the PTEN VCEP Version 3.2 specification explicitly designates BP3 as not applicable.
cspec
BP4 N/A Not applicable: the upstream c.-491_-486 duplication has protein consequence p.? and is outside BP4's missense or intronic/splice-region scope.
cspec
BP5 Not assessed Not assessed: no two qualifying cases with a highly penetrant alternate molecular diagnosis and non-overlapping personal or family history are documented.
cspec
BP6 N/A Not applicable: no exact-variant ClinVar expert-panel Benign or Likely benign classification exists, and PTEN VCEP marks BP6 unavailable.
cspec clinvar
BP7 N/A Not applicable: the upstream c.-491_-486 duplication is not annotated as synonymous or intronic, so BP7's scope does not apply.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.